Isoform-Selective HDAC Inhibitor Therapy for Transplantation: Are We Ready for HDAC6?

Transplantation. 2016 Aug;100(8):1597-8. doi: 10.1097/TP.0000000000001209.

Author

Wayne W Hancock¹

Affiliation

¹ 1 Division of Transplant Immunology, Department of Pathology and Laboratory Medicine, and Biesecker Center for Pediatric Liver Diseases, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

Histone Deacetylase 6
Histone Deacetylase Inhibitors*
Histone Deacetylases*
Humans
Hydroxamic Acids
Protein Isoforms

Substances

Histone Deacetylase Inhibitors
Hydroxamic Acids
Protein Isoforms
Histone Deacetylase 6
Histone Deacetylases

Grants and funding